Xylem Inc. (XYL) Position Raised by Tredje AP fonden

Tredje AP fonden raised its position in shares of Xylem Inc. (NYSE:XYL) by 49.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,235 shares of the company’s stock after buying an additional 8,695 shares during the period. Tredje AP fonden’s holdings in Xylem were worth $1,299,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of XYL. Private Advisor Group LLC acquired a new stake in shares of Xylem during the fourth quarter worth $774,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Xylem by 0.5% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,284 shares of the company’s stock worth $509,000 after buying an additional 50 shares during the period. State Street Corp raised its stake in shares of Xylem by 5.2% in the fourth quarter. State Street Corp now owns 7,484,675 shares of the company’s stock worth $370,649,000 after buying an additional 371,440 shares during the period. Cleararc Capital Inc. raised its stake in shares of Xylem by 632.3% in the fourth quarter. Cleararc Capital Inc. now owns 35,919 shares of the company’s stock worth $1,779,000 after buying an additional 31,014 shares during the period. Finally, Comerica Bank raised its stake in shares of Xylem by 2.1% in the fourth quarter. Comerica Bank now owns 86,960 shares of the company’s stock worth $4,240,000 after buying an additional 1,811 shares during the period. Hedge funds and other institutional investors own 86.57% of the company’s stock.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Xylem Inc. (NYSE:XYL) traded down 0.86% on Friday, reaching $47.34. The company’s stock had a trading volume of 129,366 shares. The stock’s 50 day moving average is $48.84 and its 200-day moving average is $50.06. Xylem Inc. has a 52 week low of $36.42 and a 52 week high of $54.99. The firm has a market capitalization of $8.50 billion, a PE ratio of 32.65 and a beta of 1.21.

This article was originally published by and is the sole property of Zolmax. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://zolmax.com/investing/xylem-inc-xyl-position-raised-by-tredje-ap-fonden/1208313.html

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, February 2nd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. Xylem had a return on equity of 16.64% and a net margin of 6.89%. The company earned $1.10 billion during the quarter, compared to analysts’ expectations of $1.13 billion. During the same quarter in the previous year, the firm earned $0.60 earnings per share. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. Analysts predict that Xylem Inc. will post $2.29 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 15th. Shareholders of record on Thursday, February 16th will be given a $0.18 dividend. The ex-dividend date is Tuesday, February 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.51%. This is a boost from Xylem’s previous quarterly dividend of $0.15. Xylem’s payout ratio is currently 42.76%.

This story was originally reported by Zolmax and is the sole property of of Zolmax. If you are reading this story on another site, it was copied illegally and reposted in violation of international trademark & copyright law. The original version of this story can be viewed at https://zolmax.com/investing/xylem-inc-xyl-position-raised-by-tredje-ap-fonden/1208313.html.

A number of equities research analysts have weighed in on the company. Canaccord Genuity restated a “hold” rating and set a $50.00 price objective on shares of Xylem in a research note on Wednesday, February 8th. Zacks Investment Research upgraded Xylem from a “sell” rating to a “hold” rating in a research note on Monday, February 6th. Boenning Scattergood upgraded Xylem from a “neutral” rating to an “outperform” rating and set a $55.00 price objective for the company in a research note on Friday, February 3rd. RBC Capital Markets raised their price objective on Xylem from $55.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, February 3rd. Finally, Royal Bank Of Canada raised their price objective on Xylem from $55.00 to $56.00 and gave the company an “outperform” rating in a research note on Friday, February 3rd. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $51.00.

About Xylem

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Illumina, Inc.  Upgraded to Strong-Buy at Vetr Inc.
Illumina, Inc. Upgraded to Strong-Buy at Vetr Inc.
Jefferies Group Research Analysts Reduce Earnings Estimates for Medtronic PLC
Jefferies Group Research Analysts Reduce Earnings Estimates for Medtronic PLC
Flinton Capital Management LLC Invests $458,000 in PVH Corp.
Flinton Capital Management LLC Invests $458,000 in PVH Corp.
Champlain Investment Partners LLC Acquires 106,485 Shares of Laboratory Corp. of America Holdings
Champlain Investment Partners LLC Acquires 106,485 Shares of Laboratory Corp. of America Holdings
Ross Stores, Inc.  Stake Boosted by Cantab Capital Partners LLP
Ross Stores, Inc. Stake Boosted by Cantab Capital Partners LLP
Gentherm’s  Outperform Rating Reaffirmed at FBR & Co
Gentherm’s Outperform Rating Reaffirmed at FBR & Co


Leave a Reply

 
© 2006-2017 Zolmax.